The past two decades have seen a surge in kidney disease with a significant impact on morbidity and mortality worldwide. An estimated 5 million to 10 million deaths are attributable to kidney disease annually (1–3). This has economic repercussions worldwide, with a larger estimated impact on low- and middle-income countries.
Multiple organizations have developed campaigns to increase awareness among both physicians and the public. For example, the International Society of Nephrology’s (ISN) “0 by 25” program aims to prevent avoidable death from acute kidney injury by 2025 in low- and middle-income